Here are 10 orthopedic and spine device company financial reports.
ArthroCare reported $83.3 million during 3Q, a 3.7 percent decrease from the same period last year. The company's worldwide sports medicine sales experienced a 1.6 percent increase.
Biomet experienced a 4 percent increase in net sales during 2Q of the 2012 fiscal year, despite a 5 percent drop in worldwide spine sales. This comes after a 10 percent drop in spine sales during 1Q of FY 2012.
Johnson & Johnson's DePuy Orthopaedics reported a 1.5 percent decrease in U.S. sales during 3Q of 2011. Worldwide sales increased by 5.7 percent. J&J reported $109 million in total expenses due to litigation related to the DePuy ASR Hip implant recall last year.
Medtronic reported 2Q revenue of $4.1 billion, which is a 6 percent increase over 2Q 2010. The company's success was driven by international revenue. Its spinal business reported 4 percent decrease in biologics due to poor sales of Infuse.
Orthofix reported 3Q net sales of $144.7 million, representing a 4 percent increase over 3Q of 2010. The company suffered a 1 percent decrease in spinal products, but growth in orthopedics & sports medicine.
Revenue was up for Smith & Nephew during 3Q, despite poor market growth from its orthopedics business. The company's overall revenue increased by 10 percent to $1 billion, but orthopedics sales only increased by 3 percent.
Stryker's net sales showed a 14.9 percent increase during 3Q. The company reported $2 billion in net sales, but net earnings decreased by 3 percent. The company's spine business grew by 121 percent to $184 million.
For the first time, Synthes' quarterly revenue exceeded $1 billion, an 11 percent increase over last year. The company experienced double-digit growth in the international markets.
Wright Medical Group reported a 3 percent decrease in net sales during 3Q to $118.2 million. Domestic sales decreased by 7 percent while international sales only grew by 3.6 percent. Knee, hip and biologics sales decreased.
Overseas markets drove Zimmer's 6.9 percent sales increase during 3Q. The company reported net sales of $1 million, due to a 17 percent increase in the European market. The American market remained flat.
Related Articles on Orthopedic Devices:
Zyga Technology Names Jim Bullock President & CEO
Zimmer Acquires Synvasive Technology
VG Innovations Releases Spine Device for Low Back Pain
ArthroCare reported $83.3 million during 3Q, a 3.7 percent decrease from the same period last year. The company's worldwide sports medicine sales experienced a 1.6 percent increase.
Biomet experienced a 4 percent increase in net sales during 2Q of the 2012 fiscal year, despite a 5 percent drop in worldwide spine sales. This comes after a 10 percent drop in spine sales during 1Q of FY 2012.
Johnson & Johnson's DePuy Orthopaedics reported a 1.5 percent decrease in U.S. sales during 3Q of 2011. Worldwide sales increased by 5.7 percent. J&J reported $109 million in total expenses due to litigation related to the DePuy ASR Hip implant recall last year.
Medtronic reported 2Q revenue of $4.1 billion, which is a 6 percent increase over 2Q 2010. The company's success was driven by international revenue. Its spinal business reported 4 percent decrease in biologics due to poor sales of Infuse.
Orthofix reported 3Q net sales of $144.7 million, representing a 4 percent increase over 3Q of 2010. The company suffered a 1 percent decrease in spinal products, but growth in orthopedics & sports medicine.
Revenue was up for Smith & Nephew during 3Q, despite poor market growth from its orthopedics business. The company's overall revenue increased by 10 percent to $1 billion, but orthopedics sales only increased by 3 percent.
Stryker's net sales showed a 14.9 percent increase during 3Q. The company reported $2 billion in net sales, but net earnings decreased by 3 percent. The company's spine business grew by 121 percent to $184 million.
For the first time, Synthes' quarterly revenue exceeded $1 billion, an 11 percent increase over last year. The company experienced double-digit growth in the international markets.
Wright Medical Group reported a 3 percent decrease in net sales during 3Q to $118.2 million. Domestic sales decreased by 7 percent while international sales only grew by 3.6 percent. Knee, hip and biologics sales decreased.
Overseas markets drove Zimmer's 6.9 percent sales increase during 3Q. The company reported net sales of $1 million, due to a 17 percent increase in the European market. The American market remained flat.
Related Articles on Orthopedic Devices:
Zyga Technology Names Jim Bullock President & CEO
Zimmer Acquires Synvasive Technology
VG Innovations Releases Spine Device for Low Back Pain